These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


368 related items for PubMed ID: 14742915

  • 1. The pharmacology of adrenomedullin receptors and their relationship to CGRP receptors.
    Hay DL, Conner AC, Howitt SG, Smith DM, Poyner DR.
    J Mol Neurosci; 2004; 22(1-2):105-13. PubMed ID: 14742915
    [Abstract] [Full Text] [Related]

  • 2. CL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin22-52, CGRP8-37 and BIBN4096BS.
    Hay DL, Howitt SG, Conner AC, Schindler M, Smith DM, Poyner DR.
    Br J Pharmacol; 2003 Oct; 140(3):477-86. PubMed ID: 12970090
    [Abstract] [Full Text] [Related]

  • 3. Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors: identification, pharmacological characterization, and interactions with position 74 in receptor activity-modifying protein 1/3.
    Robinson SD, Aitken JF, Bailey RJ, Poyner DR, Hay DL.
    J Pharmacol Exp Ther; 2009 Nov; 331(2):513-21. PubMed ID: 19644039
    [Abstract] [Full Text] [Related]

  • 4. Structure-function analyses reveal a triple β-turn receptor-bound conformation of adrenomedullin 2/intermedin and enable peptide antagonist design.
    Roehrkasse AM, Booe JM, Lee SM, Warner ML, Pioszak AA.
    J Biol Chem; 2018 Oct 12; 293(41):15840-15854. PubMed ID: 30139742
    [Abstract] [Full Text] [Related]

  • 5. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
    Qi T, Christopoulos G, Bailey RJ, Christopoulos A, Sexton PM, Hay DL.
    Mol Pharmacol; 2008 Oct 12; 74(4):1059-71. PubMed ID: 18593822
    [Abstract] [Full Text] [Related]

  • 6. The calcitonin receptor-like receptor/receptor activity-modifying protein 1 heterodimer can function as a calcitonin gene-related peptide-(8-37)-sensitive adrenomedullin receptor.
    Nagoshi Y, Kuwasako K, Ito K, Uemura T, Kato J, Kitamura K, Eto T.
    Eur J Pharmacol; 2002 Aug 30; 450(3):237-43. PubMed ID: 12208315
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Changes in the expression of calcitonin receptor-like receptor, receptor activity-modifying protein (RAMP) 1, RAMP2, and RAMP3 in rat uterus during pregnancy, labor, and by steroid hormone treatments.
    Thota C, Gangula PR, Dong YL, Yallampalli C.
    Biol Reprod; 2003 Oct 30; 69(4):1432-7. PubMed ID: 12801991
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1.
    Bühlmann N, Leuthäuser K, Muff R, Fischer JA, Born W.
    Endocrinology; 1999 Jun 30; 140(6):2883-90. PubMed ID: 10342881
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Glycosylation of human CRLR at Asn123 is required for ligand binding and signaling.
    Kamitani S, Sakata T.
    Biochim Biophys Acta; 2001 May 28; 1539(1-2):131-9. PubMed ID: 11389975
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.